drugset / Trial / NCT00045734
Imatinib Mesylate in Treating Patients With Recurrent Meningioma
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of imatinib mesylate in treating patients who have recurrent meningioma. Imatinib mesylate may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth
Timeline
- Start
- 2003-02
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Imatinib | Small molecule | — | Oral |